dlt446 dlt446

dlt446 dlt446

Clinical Professor

Member of:

  • Neurology


  1. 2024
  2. Published

    Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial

    Raffaelli, B., Do, T. P., Chaudhry, B. A., Amin, Faisal Mohammad, Ashina, H., Snellman, J., Maio-Twofoot, T. & dlt446, dlt446, 2024, In: Cephalalgia : an international journal of headache. 44, 1, 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Clinical features of migraine with aura: a REFORM study

    Thomsen, A. V., Ashina, H., Al-Khazali, Haidar Muhsen Abdellah, Rose, K., Christensen, R. H., Amin, Faisal Mohammad & dlt446, dlt446, 2024, In: Journal of Headache and Pain. 25, 1, 10 p., 22.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Effects of PDE-3 inhibition in persistent post-traumatic headache: evidence of cAMP-dependent signaling

    Al-Khazali, Haidar Muhsen Abdellah, Christensen, R. H., Chaudhry, B. A., Melchior, A. G., dlt446, dlt446, Burstein, R. & Ashina, H., 2024, In: Journal of Headache and Pain. 25, 1, 10 p., 56.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study

    Pozo-Rosich, P., dlt446, dlt446, Tepper, S. J., Jensen, S., Boserup, L. P., Josiassen, M. K. & Sperling, B., 2024, In: Neurology and Therapy. 13, 2, p. 339-353 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury

    Ashina, H., Diener, H. C., Tassorelli, C., Scher, A. I., Lipton, R. B., Pozo-Rosich, P., Sinclair, A. J., Chong, C. D., Finkel, A. G., dlt446, dlt446, Schwedt, T. J., Dodick, D. W. & Terwindt, G. M., 2024, In: Cephalalgia : an international journal of headache. 44, 3, 18 p.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura

    Thomsen, A. V., Al-Karagholi, M. A. M., Hougaard, A., Ostrowski, Sisse Rye, Pedersen, O. B., Hansen, Thomas Folkmann & dlt446, dlt446, 2024, In: Cephalalgia : an international journal of headache. 44, 3, 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Pharmacotherapies for Migraine and Translating Evidence From Bench to Bedside

    dlt446, dlt446, Hoffmann, J., Ashina, H., Hay, D. L., Flores-Montanez, Y., Do, T. P., De Icco, R. & Dodick, D. W., 2024, In: Mayo Clinic Proceedings. 99, 2, p. 285-299 15 p.

    Research output: Contribution to journalReviewResearchpeer-review

  9. Published

    Postdromal symptoms in migraine: a REFORM study

    Thuraiaiyah, J., Ashina, H., Christensen, R. H., Al-Khazali, Haidar Muhsen Abdellah & dlt446, dlt446, 2024, In: Journal of Headache and Pain. 25, 1, 11 p., 25.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Premonitory symptoms in migraine: A REFORM Study

    Thuraiaiyah, J., Ashina, H., Christensen, R. H., Al-Khazali, Haidar Muhsen Abdellah, Wiggers, A., Amin, Faisal Mohammad, Steiner, Timothy & dlt446, dlt446, 2024, In: Cephalalgia. 44, 2, 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial

    dlt446, dlt446, Lipton, R. B., Ailani, J., Versijpt, J., Sacco, S., Mitsikostas, D. D., Christoffersen, C. L., Sperling, B. & Ettrup, A., 2024, In: European Journal of Neurology. 31, 2, e16131.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials

    Rizzoli, P., Marmura, M. J., Robblee, J., McVige, J., Sacco, S., Nahas, S. J., Ailani, J., De Abreu Ferreira, R., Ma, J., Smith, J. H., Dabruzzo, B. & dlt446, dlt446, 2024, In: Journal of Headache and Pain. 25, 1, 10 p., 35.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention

    Pellesi, L., dlt446, dlt446 & Martelletti, P., 2024, In: Expert Opinion on Emerging Drugs. 29, 1, p. 57-64 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  14. 2023
  15. Published

    Adenosine causes short-lasting vasodilation and headache but not migraine attacks in migraine patients: a randomized clinical trial

    Thuraiaiyah, J., Al-Karagholi, M. A., Elbahi, F. A., Zhuang, Z. A. & dlt446, dlt446, 2023, In: Pain. 164, 5, p. 1118-1127 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    An exploratory analysis of clinical and sociodemographic factors in CGRP-induced migraine attacks: A REFORM study

    Al-Khazali, Haidar Muhsen Abdellah, Ashina, H., Christensen, R. H., Wiggers, A., Rose, K., Iljazi, A., Schytz, Henrik Winther, Amin, Faisal Mohammad & dlt446, dlt446, 2023, In: Cephalalgia. 43, 10, 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial

    Pozo-Rosich, P., Ailani, J., dlt446, dlt446, Goadsby, P. J., Lipton, R. B., Reuter, U., Guo, H., Schwefel, B., Lu, K., Boinpally, R., Miceli, R., De Abreu Ferreira, R., McCusker, E., Yu, S. Y., Severt, L., Finnegan, M. & Trugman, J. M., 2023, In: The Lancet. 402, 10404, p. 775-785 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Calcitonin gene-related peptide causes migraine aura

    Al-Khazali, Haidar Muhsen Abdellah, Ashina, H., Wiggers, A., Rose, K., Iljazi, A., Christensen, R. H., Schytz, Henrik Winther, Amin, Faisal Mohammad & dlt446, dlt446, 2023, In: Journal of Headache and Pain. 24, 1, 13 p., 124.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Characterizing healthcare utilization patterns in a Danish population with headache: results from the nationwide headache in Denmark (HINDER) panel

    Do, T. P., Dømgaard, M., Stefansen, S., Steiner, Timothy & dlt446, dlt446, 2023, In: Journal of Headache and Pain. 24, 1, 18.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Design of the contemporary prospective understanding of migraine real-world evidence (CAPTURE) study

    Lanteri-minet, M., Tassorelli, C., dlt446, dlt446, Goadsby, P., Katsarava, Z., Matharu, M., Peres, M., Stark, R., Ailani, J., Leroux, E., Delahaye, L., Ha, H. & Pozo-rosich, P., 2023, In: Journal of the Neurological Sciences. 455, Supplement, p. 214 1 p., 121668.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  21. Published

    Glibenclamide Posttreatment Does Not Inhibit Levcromakalim Induced Headache in Healthy Participants: A Randomized Clinical Trial

    Kokoti, L., Al-Karagholi, M. A. M., Waldorff Nielsen, C. A. & dlt446, dlt446, 2023, In: Neurotherapeutics. 20, 2, p. 389-398 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Investigations of the subarachnoid space as a potential link between aura and headache in migraine: A case-control MRI study

    Thomsen, A. V., Puonti, O., Gaist, D., Kyvik, K. O., Madsen, K., Thielscher, A., Siebner, Hartwig Roman, dlt446, dlt446 & Hougaard, A., 2023, In: Cephalalgia. 43, 6, 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Lack of reproducibility of resting-state functional MRI findings in migraine with aura

    Hougaard, Anders, Gaist, D., Garde, Ellen, Iversen, P., Madsen, C. G., Kyvik, K. O., dlt446, dlt446, Siebner, Hartwig Roman & Madsen, K. H., 2023, In: Cephalalgia : an international journal of headache. 43, 11, 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial

    dlt446, dlt446, Tepper, S. J., Gendolla, A., Sperling, B., Ettrup, A., Josiassen, M. K. & Starling, A. J., 2023, In: Journal of Headache and Pain. 24, 1, 13 p., 155.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis

    Tepper, S. J., Lipton, R. B., Silberstein, S. D., Kudrow, D., dlt446, dlt446, Reuter, U., Dodick, D. W., Wang, A., Cheng, S., Klatt, J. & Mikol, D. D., 2023, In: Headache. 63, 6, p. 730-742 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial

    dlt446, dlt446, Roos, C., Li, L. Q., Komori, M., Ayer, D., Ruff, D. & Krege, J. H., 2023, In: Cephalalgia. 43, 4, 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence

    Raffaelli, B., Do, T. P., Chaudhry, B. A., dlt446, dlt446, Amin, Faisal Mohammad & Ashina, H., 2023, In: Journal of Headache and Pain. 24, 1, 10 p., 131.

    Research output: Contribution to journalReviewResearchpeer-review

  28. Published

    Migraine aura-like episodes following sclerotherapy for varicose veins of the lower extremities — A systematic review

    Bahtiri, L., Thomsen, A. V., dlt446, dlt446 & Hougaard, A., 2023, In: Headache. 63, 1, p. 40-50 11 p.

    Research output: Contribution to journalReviewResearchpeer-review

  29. Published

    Migraine in older adults

    Hugger, S. S., Do, T. P., Ashina, H., Goicochea, M. T., Jenkins, B., Sacco, S., Lee, M. J., Brennan, K. C., Amin, Faisal Mohammad, Steiner, Timothy & dlt446, dlt446, 2023, In: The Lancet Neurology. 22, 10, p. 934-945 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  30. Published

    Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis

    dlt446, dlt446, Mitsikostas, D. D., Ramirez Campos, V., Barash, S., Ning, X. & Diener, H. C., 2023, In: Headache. 63, 10, p. 1351-1358

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial

    dlt446, dlt446, Tepper, S. J., Reuter, U., Blumenfeld, A. M., Hutchinson, S., Xia, J., Miceli, R., Severt, L., Finnegan, M. & Trugman, J. M., 2023, In: Headache. 63, 1, p. 79-88 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial

    Lipton, R. B., Halker Singh, R. B., Mechtler, L., McVige, J., Ma, J., Yu, S. Y., Stokes, J., Dabruzzo, B., Gandhi, P. & dlt446, dlt446, 2023, In: Cephalalgia. 43, 9, p. 1-10

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies

    de Boer, I., Verhagen, I. E., Souza, M. N. P. & dlt446, dlt446, 2023, In: Cephalalgia. 43, 2, p. 1-13

    Research output: Contribution to journalReviewResearchpeer-review

  34. Published

    Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?

    Basedau, H., Ornello, R., Matteis, E. D., Davaasuren, B., Kadyrova, B., Vuralli, D., Bozhenko, M., Azizova, I., Bitsadze, N., Eralieva, E., dlt446, dlt446, Mitsikostas, D. & Puledda, F., 2023, In: Cephalalgia. 43, 12, p. 1-12

    Research output: Contribution to journalReviewResearchpeer-review

  35. Published

    Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study

    Deligianni, C., Pellesi, L., Chaudhry, B. A., Haulund Vollesen, A. L., Snoer, A. H., Hannibal, Jens, Jensen, Rigmor Højland & dlt446, dlt446, 2023, In: Frontiers in Neurology. 14, 8 p., 1135246.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    Prolactin in headache and migraine: A systematic review of clinical studies

    Al-Karagholi, M. A. M., Kalatharan, V., Ghanizada, Hashmat, Gram, C., Dussor, G. & dlt446, dlt446, 2023, In: Cephalalgia. 43, 2, 19 p.

    Research output: Contribution to journalReviewResearchpeer-review

  37. Published

    Prolactin in headache and migraine: A systematic review of preclinical studies

    Al-Karagholi, M. A. M., Kalatharan, V., Ghanizada, Hashmat, Dussor, G. & dlt446, dlt446, 2023, In: Headache. 63, 5, p. 577-584 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  38. Published

    Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study

    dlt446, dlt446, Mitsikostas, D. D., Amin, Faisal Mohammad, Kokturk, P., Schankin, C. J., Sahin, G., Pozo-Rosich, P., Dorman, P. J., Nežádal, T., Poole, A. C., Martins, I. P., Sumelahti, M. L., Ramirez Campos, V., Ahn, A. H., Lyras, L. & Tassorelli, C., 2023, In: Cephalalgia. 43, 11, 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030

    Martelletti, P., Leonardi, M., Ashina, M., Burstein, R., Cho, S. J., Charway-Felli, A., Dodick, D. W., Gil-Gouveia, R., Grazzi, L., Lampl, C., MaassenVanDenBrink, A., Minen, M. T., Mitsikostas, D. D., Olesen, J., Owolabi, M. O., Reuter, U., Ruiz de la Torre, E., Sacco, S., Schwedt, T. J., Serafini, G. & 6 others, Surya, N., Tassorelli, C., Wang, S. J., Wang, Y., Wijeratne, T. & Raggi, A., 2023, In: Journal of Headache and Pain. 24, 1, 17 p., 140.

    Research output: Contribution to journalReviewResearchpeer-review

  40. Published

    Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans

    Do, T. P., Deligianni, C., Amirguliyev, S., Snellman, J., Lopez, C. L., Al-Karagholi, M. A. M., Guo, S. & dlt446, dlt446, 2023, In: Brain. 146, 12, p. 5224-5234 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics

    Karlsson, W. K., Ashina, H., Cullum, C. K., Christensen, R. H., Al-Khazali, Haidar Muhsen Abdellah, Amin, Faisal Mohammad, dlt446, dlt446 & REFORM Investigators, R. I., 2023, In: Journal of Headache and Pain. 24, 12 p., 70.

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study

    Rasmussen, N. B., Deligianni, C., Christensen, C. E., Karlsson, W. K., Al-Khazali, Haidar Muhsen Abdellah, Van de Casteele, T., Granhall, C., Amin, Faisal Mohammad & dlt446, dlt446, 2023, In: Journal of Headache and Pain. 24, 60.

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. Published

    Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity

    Wienholtz, N. K. F., Thyssen, J. P., Christensen, C. E., Thomsen, S. F., Karmisholt, K. E., Jemec, G. B. E., Lomholt, H. B., Heidenheim, M., Simonsen, A. B., Sand, C., Vestergaard, C., Kaur-Knudsen, D., Ammitzbøll, E., Lørup, E., Danielsen, A. G., Strauss, G., Skov, L., Andersen, P. H., Hald, M., Idorn, L. W. & 3 others, dlt446, dlt446, Zachariae, Claus & Egeberg, Alexander, 2023, In: Journal of the European Academy of Dermatology and Venereology. 37, 3, p. 573-580 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. Published

    What proportion of people with migraine report postdromal symptoms? A systematic review and meta-analysis of observational studies

    Christensen, R. H., Eigenbrodt, A. K., Ashina, H., Steiner, Timothy & dlt446, dlt446, 2023, In: Cephalalgia. 43, 10, 11 p.

    Research output: Contribution to journalReviewResearchpeer-review

  45. 2022
  46. Published

    Brain barriers and their potential role in migraine pathophysiology

    Wiggers, A., Ashina, H., Hadjikhani, N., Sagare, A., Zlokovic, B. V., Lauritzen, Martin & dlt446, dlt446, Dec 2022, In: Journal of Headache and Pain. 23, 1, 10 p., 16.

    Research output: Contribution to journalReviewResearchpeer-review

  47. Published

    Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study

    Pellesi, L., Al-Karagholi, M. A. M., De Icco, R., Chaudhry, B. A., Lopez, C. L., Snellman, J., Hannibal, Jens, Amin, Faisal Mohammad & dlt446, dlt446, 1 Apr 2022, In: Frontiers in Neurology. 13, 7 p., 871176.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Assessment of Erenumab Safety and Efficacy in Patients with Migraine with and Without Aura: A Secondary Analysis of Randomized Clinical Trials

    dlt446, dlt446, Goadsby, P. J., Dodick, D. W., Tepper, S. J., Xue, F., Zhang, F., Brennan, F. & Paiva Da Silva Lima, G., Feb 2022, In: JAMA Neurology. 79, 2, p. 159-168 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Arterial responses to infusion of glucagon-like peptide-1 in humans: A randomized trial study

    Ghanizada, Hashmat, Christensen, R. H., Al-Karagholi, M. A. M., Elbahi, F. A., Coskun, H. & dlt446, dlt446, 2022, In: Peptides. 150, 8 p., 170736.

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. Published

    Barriers and gaps in headache education: a national cross-sectional survey of neurology residents in Denmark

    Do, T. P., Dømgaard, M., Stefansen, S., Kristoffersen, E. S., dlt446, dlt446 & Hansen, J. M., 2022, In: BMC Medical Education. 22, 1, 233.

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. Published

    Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America

    Lisicki, M., Souza, M. N. P., de Oliveira, A. B., Rubio-Beltrán, E., Labastida-Ramirez, A., dlt446, dlt446 & Peres, M., 2022, In: Cephalalgia. 42, 10, p. 1086-1090 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  52. Published

    Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis

    Christensen, C. E., dlt446, dlt446 & Amin, Faisal Mohammad, 2022, In: Pharmaceuticals. 15, 10, 11 p., 1189.

    Research output: Contribution to journalReviewResearchpeer-review

  53. Published

    Calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in migraine treatment

    Dominguez-Moreno, R., Do, T. P. & dlt446, dlt446, 2022, In: Current Opinion in Endocrinology, Diabetes and Obesity. 29, 2, p. 225-231 7 p.

    Research output: Contribution to journalReviewResearchpeer-review

Previous 1 2 3 4 5 6 7 8 Next

ID: 920785